2nd Clinical Site for Gene Therapy Trial for Usher Syndrome

July 26, 2012

The Foundation Fighting Blindness and Oxford BioMedica announced funding for a second clinical site to conduct a gene therapy trial for Ushers Syndrome. The site will be the Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts in Paris, and will join the ongoing clinical trial being held at the Oregon Health & Science University’s Casey Eye Institute.

To read all of the details, please follow this link.




Jump down to form below to submit your own comments

Comments are closed.